LFCR Stock Analysis: Buy, Sell, or Hold?
LFCR - Lifecore Biomedical, Inc. Common Stock
$8.69
0.18 (2.12%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Jan 01, 2026
0d
Get Alerted When LFCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LFCR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: LFCR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LFCR is currently trading at $8.69, which is considered extended relative to its 30-day fair value range of $7.78 to $8.54.
Technical Outlook: Technically, LFCR is in a strong uptrend. Immediate support is located at $7.95, while resistance sits at $8.98.
Market Sentiment: LFCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LFCR is in a strong uptrend. Immediate support is located at $7.95, while resistance sits at $8.98.
Market Sentiment: LFCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$7.78 -
$8.54
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($9.25)
Fair Price Analysis
30-Day Fair Range
$7.78 -
$8.54
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$0.84
(9.7%)
Support & Resistance Levels
Support Level
$7.95
Resistance Level
$8.98
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-15.94
Wall Street Target
$9.25
(+6.4%)
Revenue Growth (YoY)
-3.8%
Profit Margin
-30.0%
Last updated: February 01, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced LFCR Option Strategies
Professional options setups generated by AI based on today's LFCR price and gamma walls.
